Bank of America Downgrades Quest Diagnostics To Underperform

Loading...
Loading...
Analysts at Bank of America downgraded
Quest Diagnostics Inc.DGX
from Neutral to Underperform. Quest Diagnostics shares have gained 33.38% over the past 52 weeks, while the S&P 500 index has surged 14.22% in the same period. Quest Diagnostics' shares surged 0.45% to close at $71.77 on Friday
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsBank of America
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...